Main Street Group’s Teladoc Health TDOC Stock Holding History

Main Street Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10	Closed	-$151	–	928
2024 Q1	$151	Buy	+10	New	+$181	﹤0.01%	880

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Main Street Group's TDOC Position: Q2 2024 in Review

Main Street Group sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 10 shares — an estimated $151 sold.

Main Street Group first reported a position in TDOC in Q1 2024 and held it in 1 quarter. The position peaked at $151 in Q1 2024. 405 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

Main Street Group reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
Main Street Group sold 10 Teladoc Health shares in Q2 2024, an estimated $151.
Main Street Group first reported a position in Teladoc Health in Q1 2024 and held it in 1 quarter.
Main Street Group's Teladoc Health position peaked at $151 in Q1 2024.
405 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Main Street Group's 13F filing for Q2 2024, filed 6 Aug 2024.